News From Around the System

NIH Awards UC San Diego Researchers $14.3 Million to Continue 4D Nucleome Research

Funding supports advanced investigations into how DNA organizes inside cell nuclei and functions in space and time; UC San Diego is the national research hub

Studies Find Even Minimal Physical Activity Measurably Boosts Health

Two research teams at UC San Diego School of Medicine sought to understand sedentary lifestyles, with one study finding that even light physical activity, including just standing, can benefit health, and the other that Americans are sitting too much.

Studies Find Even Minimal Physical Activity Measurably Boosts Health

Two new studies from UC San Diego find that simply standing up or walking around can provide positive health benefits; and Americans sit too much

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions

UC San Diego School of Medicine researchers report that older adults are increasingly using cannabis to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions

Data indicates 61 percent of patients who used cannabis began after age 60

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

J. Silvio Gutkind, PhD, has been named chair of the Department of Pharmacology at UC San Diego School of Medicine.

J. Silvio Gutkind, PhD, Named Chair of the Department of Pharmacology

Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study

Patients receiving care at Moores Cancer Center at UC San Diego Health had better outcomes if they received personalized cancer therapy.

Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study

UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine

UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.